Division of GlaxoSmithKline PLC
Latest From GlaxoSmithKline KK
Pfizer Japan, Novartis Pharma KK, Chugai Pharmaceutical, GlaxoSmithKline KK and other Japan subsidiaries or allies of foreign drug makers are planning to introduce new cancer drugs in the country.
The Dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.
Japanese drug makers plan to exceed last year’s record-setting influenza dosages by producing enough for nearly 30 million patients this season.
- OTC, Consumer
- Therapeutic Areas
- Pacific Rim
- Parent & Subsidiaries
- GlaxoSmithKline PLC
- Senior Management
- Philippe Fauchet, Pres.
- Contact Info
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.